No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IINN Inspira Technologies Oxy
- 1.180
- -0.030-2.48%
Trading Jul 22 10:40 ET
20.55MMarket Cap-1268P/E (TTM)
1.230High1.100Low57.98KVolume1.190Open1.210Pre Close67.64KTurnover0.54%Turnover RatioLossP/E (Static)17.41MShares2.49052wk High3.58P/B12.59MFloat Cap0.76152wk Low--Dividend TTM10.67MShs Float9.590Historical High--Div YieldTTM10.74%Amplitude0.761Historical Low1.166Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Inspira Shares Are Trading Higher After the Company Received Israeli Regulatory Approval for the INSPIRA ART100 System
Express News | Inspira™ Receives Israeli Regulatory Approval for the Inspira™ Art100 System
Express News | Inspira Technologies Oxy BHN Ltd: On Track to Submit Hyla Blood Sensor for FDA Clearance
InspiraTM Announces Business Plan Targets
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company,...
6-K: Report of foreign private issuer (related to financial reporting)
InspiraTM Introduces Advanced Life Support Solutions to Key International Leaders at the Annual IECOs Conference in Israel
Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology...
Comments
$Inspira Technologies Oxy(IINN.US$ Inspira™ Receives Israeli Regulatory Approval for the Inspira™ Art100 System
$Inspira Technologies Oxy(IINN.US$
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
Inspira Technologies OXY B.H.N. (Nasdaq: IINN, IINNW) announced significant milestones, including FDA clearance for its INSPIRA™ ART100 system. The company will present its business targets and distribution agreements in a conference call on June 20, 2024, at 9:00 am Eastern Time. Company President and co-founder Joe Hayon will lead the discus...
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
Inspira Technologies OXY B.H.N. (Nasdaq: IINN, IINNW) announced significant milestones, including FDA clearance for its INSPIRA™ ART100 system. The company will present its business targets and distribution agreements in a conference call on June 20, 2024, at 9:00 am Eastern Time. Company President and co-founder Joe Hayon will lead the discus...
2
$Inspira Technologies Oxy(IINN.US$
INSPIRA™ ART100 Receives FDA 510(k) Clearance
Inspira Technologies OXY announced that its INSPIRA™ ART100 Cardiopulmonary Bypass System has received 510(k) class II clearance from the FDA. The FDA clearance is a significant milestone for the company, suggesting technological and innovative advancements. CEO Dagi Ben Noon and Chairman Professor Benad Goldwasser expressed their appreciation for investors and partners and highlighted the strategic importance ...
INSPIRA™ ART100 Receives FDA 510(k) Clearance
Inspira Technologies OXY announced that its INSPIRA™ ART100 Cardiopulmonary Bypass System has received 510(k) class II clearance from the FDA. The FDA clearance is a significant milestone for the company, suggesting technological and innovative advancements. CEO Dagi Ben Noon and Chairman Professor Benad Goldwasser expressed their appreciation for investors and partners and highlighted the strategic importance ...
2
$Inspira Technologies Oxy(IINN.US$ Congratulations on this milestone. Life saving respiratory technology. Investors await the market open tomorrow morning.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg